Navigenics Receives $18,000,000 Series C Financing Round

  • Feed Type
  • Date
    2/3/2009
  • Company Name
    Navigenics
  • Mailing Address
    1001 E. Hillsdale Blvd Foster City, CA 94404
  • Company Description
    NAVIGENICS, INC. is a privately held company offering personalized, genetics-based consumer health and wellness services to our members. Our founders and advisors include leading genetic scientists, physicians, genetic counselors, bioethicists, patient advocates, health policy and technology experts and a management team that has successfully launched some of the most successful online health and information resources of our time.
  • Website
    http://www.navigenics.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $18,000,000
  • Transaction Round
    Series C
  • Proceeds Purposes
    This Series C financing will help ensure that Navigenics has the ability to continue our groundbreaking research into the impact of genomics on preventive health care, expand our clinical offerings into exciting new areas and lead the way in making personal genomics an integral part of employer-sponsored preventive health and wellness programs.
  • M&A Terms
  • Venture Investor
    Procter and Gamble Company
  • Venture Investor
    Kleiner Perkins Caufield & Byers
  • Venture Investor
    Mohr Davidow Ventures

Trending on Xconomy